Back

Association of Diabetes Care & Education Specialists

  • Non-alcoholic Fatty Liver Disease
  • Obesity

Advancing MASLD Care: A DCES Guide to Managing MASLD in People with Diabetes

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, affecting up to 70% of people with diabetes or obesity, yet remains frequently unrecognized. With rapid treatment advances, including two FDA-approved therapies for metabolic dysfunction-associated steatohepatitis (MASH), DCES can play a vital role in identifying and managing this cardiometabolic comorbidity. This session provides practical screening strategies, including FIB-4 calculation, evidence-based pharmacologic interventions following current ADA guidelines, and comprehensive diabetes management approaches for people with MASLD. Through case-based application, attendees will gain actionable tools to identify, risk-stratify, and manage MASLD in clinical practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditDietetic CPEUsUp to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No
  • Case-based learning
  • Credit · Up to 1 credit
  • Fee · varies
  • Released
    Jun 3, 2026
  • Last day to claim credit
    Jun 4, 2028 2 years left